← All trials
NCT04381832
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2020
- Primary completion
- Apr 30, 2023
- Completion date
- Oct 31, 2023
- First posted
- May 11, 2020
- Last posted
- May 22, 2020
- Enrollment
- 140
- Arms / groups
- 8 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Arcus Biosciences, Inc.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.